Citi Cuts Hospira (HSP) to Sell, Price Target Moved from $58 to $52

September 28, 2010 8:15 AM EDT Send to a Friend
An analyst at Citi downgraded shares of Hospira (NYSE: HSP) from Hold to Sell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login